Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-5-12
pubmed:abstractText
In an effort to develop octahedral metal complexes as chemotherapeutic and diagnostic agents targeted to DNA, it is critical to optimize the properties of their cellular uptake. Appending d-octaarginine has been found to improve both the uptake and nuclear localization efficiency of these complexes, but the increased positive charge interferes with selective DNA binding and hence activity. Herein, we evaluate the nuclear entry of a series of luminescent ruthenium peptide conjugates of shorter sequence and lower charge. As is the case for the d-octaarginine conjugate (Ru-D-R8), the tetrapeptide RrRK (where r=d-arginine) facilitates nuclear localization of the ruthenium complex above a threshold concentration, though the threshold is higher for this conjugate (Ru-RrRK) than for Ru-D-R8. Furthermore, appended fluorescein, which lowers the threshold concentration for Ru-D-R8, does not improve nuclear entry of Ru-RrRK, indicating that fluorescein conjugation is not a general strategy for modulating the distribution of cell-penetrating peptides. Similarly, the concentration required for nuclear entry of Ru-RrRK is much higher than has been reported for a thiazole orange RrRK conjugate, demonstrating the influence of payload on the efficiency of uptake and localization of cell-penetrating peptides.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-11087855, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-11095185, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-12379121, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-12411431, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-1420195, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-15291531, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-16254940, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-16972294, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-17014082, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-17199281, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-17587406, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-17719491, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-18420144, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-18563254, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-19175313, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-19505141, http://linkedlifedata.com/resource/pubmed/commentcorrection/20430627-8277884
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1464-3391
pubmed:author
pubmed:copyrightInfo
Copyright 2010 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3564-9
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Targeting a ruthenium complex to the nucleus with short peptides.
pubmed:affiliation
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, United States.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural